SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-441132
Filing Date
2013-11-14
Accepted
2013-11-14 07:30:31
Documents
7
Period of Report
2013-11-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d628517d8k.htm 8-K 16641
2 EX-2.1 d628517dex21.htm EX-2.1 422363
3 EX-99.1 d628517dex991.htm EX-99.1 9795
4 GRAPHIC g628517ex2_1pg12a.jpg GRAPHIC 2123
5 GRAPHIC g628517ex2_1pg12b.jpg GRAPHIC 1999
6 GRAPHIC g628517ex2_1pg12c.jpg GRAPHIC 1783
7 GRAPHIC g628517ex2_1pg12d.jpg GRAPHIC 1961
  Complete submission text file 0001193125-13-441132.txt   461580
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 131216774
SIC: 8731 Services-Commercial Physical & Biological Research